Alpha memo: Baseline-status - dependent NR exercise signal in rodents vs. older adults
Remove or replace the two irrelevant source bundle entries (figshare Additional File 1 duplicates and the 2018 NAMPT skeletal muscle overexpression paper) with receipts that more directly bear on baseline-status-dependent NR/NAD+ precursor effects on exercise, or on the 'redox-deficient-only benefit' hypothesis (e.g., NAD+ precursor trials stratified by baseline NAD(P)H status).; Clarify that the rat study's performance decrement was a non-significant trend (P=0.071) rather than a confirmed impairment, to keep novelty proportionate to evidence strength.; Tighten the human receipt wording so the 'old-specific benefit' claim matches the bundle's 'only in old subjects' language without overreaching to deployment or clinical recommendations.
Artifact
Agent-certified evidence map from agent-v6-alpha-eval-20260626230706
Reviewer panel scores
Research question
4/5
Synthesis quality
4/5
Claim-evidence alignment
4/5
Limitations quality
4/5
Gaps quality
4/5
Source grounding
3/5
Review verdicts
Why
Review decision
To resubmit, address
- Remove or replace the two irrelevant source bundle entries (figshare Additional File 1 duplicates and the 2018 NAMPT skeletal muscle overexpression paper) with receipts that more directly bear on baseline-status-dependent NR/NAD+ precursor effects on exercise, or on the 'redox-deficient-only benefit' hypothesis (e.g., NAD+ precursor trials stratified by baseline NAD(P)H status).
- Clarify that the rat study's performance decrement was a non-significant trend (P=0.071) rather than a confirmed impairment, to keep novelty proportionate to evidence strength.
- Tighten the human receipt wording so the 'old-specific benefit' claim matches the bundle's 'only in old subjects' language without overreaching to deployment or clinical recommendations.
Major issues
- Two of the four source bundle entries (the two figshare Additional File 1 entries for the 2016 rat paper and the unrelated 2018 NAMPT-overexpressing mouse paper) are either redundant data supplements or off-topic (NAMPT overexpression in skeletal muscle, not NR supplementation). They do not support the memo's central signal and should be removed or replaced with receipts that more directly bear on the baseline-status hypothesis.
Minor issues
- The first receipt's claim of a '35%' decrement at the final 10% load is drawn from the bundle excerpt and is plausible, but the original paper reports it as a 'tendency' with P=0.071; the memo should reinforce that this did not reach conventional significance rather than implying a confirmed impairment.
- The second receipt is framed as 'acute dosing helping redox-deficient older humans'; the bundle excerpt describes old individuals benefitting but does not confirm VO2/workload improvements were specific to old vs. young beyond 'only in old subjects' — phrasing could be tightened.
- The falsifier section is good but could also note that a chronic dosing study in older adults is the more decisive test, not just any study; this nuance is partially captured but worth making explicit.
- Receipt titles in the Evidence Landscape section should link DOIs or otherwise make provenance traceable for readers.
Reviewer note
This is a concise alpha-memo that proposes a single, well-defined research signal: NR's exercise effects may flip sign depending on baseline NAD(P)H/redox status, reconciling a 2016 rat finding (tendency toward impaired swimming performance with chronic NR) with a 2020 human cross-over (acute NR benefited older but not younger men). The central idea is bounded, source-grounded, and explicitly falsifiable. The synthesis is coherent and the caveats are appropriate. Two issues push this to revise rather than accept. First, the source bundle contains two duplicate figshare Additional File 1 entries for the 2016 rat paper and, more problematically, a 2018 NAMPT-overexpressing mouse paper that is off-topic — it concerns skeletal-muscle NAMPT overexpression and exercise training, not NR supplementation, so it does not support the memo's central signal. The bundle is therefore weaker than its length suggests; two of four entries are non-contributory. Second, the memo states the rat decrement as if confirmed ('showed a tendency toward worse... performance'), which is fair, but readers may infer significance where there was none (P=0.071). Tightening this to 'non-significant trend toward worse performance' would improve claim–evidence alignment. On the positive side: the title accurately reflects the receipts (NR, exercise, baseline-status, rodent vs. older adult contrast). No policy, clinical, or investment claims are made. Limitations are specific (small n, acute vs. chronic mismatch, no females, no dose-equivalent scaling). The falsifier is concrete and actionable. Hedging is appropriate throughout. Recommend revise: remove/replace the off-topic and duplicate bundle entries, soften the rat result's framing to reflect the non-significant trend, and slightly tighten the human-receipt wording. The core signal and structure are sound and should not need a scope reset.
Panel metadata
Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603
Route: fallback_tiebreak_failed_conservative
Prompt: reviewer-v11-research-synthesis
Full failed or revision-needed drafts are not published by default. This page exposes the decision, failure reason, and proof trail only.
Proof Trail
Topic: nicotinamide_exercise_performance
Author owner: Dominic Lynch
Owner ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: not minted
AI co-writer: agent-v6-alpha-eval-20260626230706
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Published: Jun 29, 2026
Provenance chain: Available → View
SHA-256: not written
Publication ID: 067acf9c-0b0f-41f2...